Skip to main content
. 2019 Oct;51(3):298–306. doi: 10.5152/eurasianjmed.2019.18101

Table 1.

Inclusion and exclusion criteria adopted to evaluate studies

Inclusion criteria:
  1. Studies with diagnostic accuracy and comparison of imaging tests with histopathological analysis

  2. Imaging tests include PR, CT, CBCT, MRI, PET, SPECT, MSCT.

  3. Patients diagnosed with OSCC

  4. Squamous cell carcinoma with bone invasion

  5. The protocol must be indicated for each imaging technique used (type of equipment, T1/T2 windows and used plane, thickness of the scans in mm) and the criteria adopted for the radiological invasion diagnosis of the bone tissue.

  6. Must describe or give sufficient information to be able to calculate the sensitivity and specificity of the imaging test.

  7. It must indicate the criteria for the histopathological diagnosis of invasion of the bone tissue.

Exclusion criteria:
  1. Prior treatment and/or recurrence for OSCC at >10% of the studied population

  2. Studies on metastatic lesions and/or lymph node invasion

  3. Repetitive studies: the oldest version will be excluded.

  4. Studies with fewer than ten participants

  5. Studies that include pharyngeal cancers

CT: computed tomography; CBCT: cone beam computed tomography; MRI: magnetic resonance imaging; MSCT: multi-slice computed tomography; OSCC: oral squamous cell carcinoma; PR: panoramic radiography; PET: positron emission tomography; SPECT: single-photon emission computed tomography